People: Bausch Health Companies Inc (BHC.TO)

BHC.TO on Toronto Stock Exchange

14 Jun 2019
Change (% chg)

$-0.27 (-0.93%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Papa, Joseph 

Mr. Joseph C. (Joe) Papa is Chairman of the Board, Chief Executive Officer of the Company. He has been our Chairman of the Board and CEO since May 2016. Mr. Papa has more than 35 years of experience in the pharmaceutical, healthcare and specialty pharmaceutical industries, including 20 years of branded prescription drug experience. He served as the CEO of Perrigo Company plc (“Perrigo”) since 2006 and was appointed as its Chairman in 2007. He resigned from all positions at Perrigo in April 2016. Prior to joining Perrigo, Mr. Papa served from December 2004 to October 2006 as Chairman and CEO of the Pharmaceutical and Technologies Services segment of Cardinal Health, Inc. From 2001 to 2004, he served as President and Chief Operating Officer of Watson Pharmaceuticals, Inc. (“Watson”). Prior to joining Watson, Mr. Papa has also held management positions at DuPont Pharmaceuticals, Pharmacia/Searle and Novartis AG. Mr. Papa has been a director of Smith & Nephew, a developer of advanced medical devices, since August 2008. The Board has determined that Mr. Papa’s extensive experience as a chief executive officer of a public company, where he demonstrated leadership capability and extensive knowledge of complex financial and operational issues facing large organizations, and his understanding of o p e r a t i o n s a n d f i n a n c i a l s t r a t e g y i n c h a l l e n g i n g environments qualify him to serve as a member of the Board. Additionally, Mr. Papa’s knowledge of the pharmaceutical industry and business, combined with his drive for innovation and excellence, position him well to serve as the Chairman of the Board.

Basic Compensation

Total Annual Compensation, USD 1,500,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 3,395,110
Fiscal Year Total, USD 4,895,110

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Joseph Papa


Paul Herendeen


Christina Ackermann


Thomas Appio


William Humphries


Thomas Ross

As Of  31 Dec 2017